Bristol unveils 10-year Opdivo + Yervoy follow-up data in melanoma
https://seekingalpha.com/news/4150032-bristol-unveils-10-year-opdivo-yervoy-follow-up-data-melanoma?source=feed_sector_healthcare
Sep 16, 2024 - Bristol-Myers Squibb's Opdivo + Yervoy combo shows durable improvement in advanced melanoma over 10 years. Read more here.
0
Ascendis Pivotal ApproaCH Study Of TransCon CNP In Achondroplasia Meets Primary Goal; Stock Up
https://www.rttnews.com/story.aspx?Id=3475366
Sep 16, 2024 - Ascendis Pharma A/S (ASND) Monday said the pivotal ApproaCH study of TransCon CNP, in children with achondroplasia met its primary goal. The company's shares were more than 17 percent up in pre-market.
0
Apple: Not Ready To Glow Up
https://seekingalpha.com/article/4721204-apple-not-ready-to-glow-up?source=feed_all_articles
Sep 15, 2024 - Apple’s recent product event, including the iPhone 16, failed to generate significant excitement due to incomplete AI features. Read why AAPL stock is a Sell.
0
The Fed has the proof it wants that inflation is slowing, but the next move is still up in the air
https://www.cnbc.com/2024/09/14/inflation-is-slowing-but-the-feds-next-move-is-still-up-in-the-air.html
Sep 15, 2024 - A week's worth of inflation data showed that price pressures have eased substantially.
0
Axel Springer and KKR near €13.5B break-up deal: FT
https://seekingalpha.com/news/4149802-axel-springer-and-kkr-near-135b-break-up-deal-ft?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Sep 14, 2024 - German billionaire Mathias Doepfner and KKR are nearing a deal to split up media giant Axel Springer, giving KKR majority control of the profitable...
0
3 Warren Buffett Stocks to Load Up on Right Now
https://www.fool.com/investing/2024/09/14/3-warren-buffett-stocks-to-load-up-on-right-now/?source=iedfolrf0000001
Sep 14, 2024 - These businesses can help you build wealth for retirement.
0
S&P soars to best week of 2024 as Wall Street gears up for anticipated interest rate cuts
https://seekingalpha.com/news/4149768-sp-soars-to-best-week-of-2024-as-wall-street-gears-up-for-anticipated-interest-rate-cuts?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Sep 13, 2024 - The S&P 500 (SP500) on Friday surged 4.02% for the week to end at 5,626.02 points, posting gains in all five sessions. Read more here.
0
Arcus up 4% following Merck Welireg kidney cancer data
https://seekingalpha.com/news/4149696-arcus-up-4-following-merck-welireg-kidney-cancer-data?source=feed_sector_healthcare
Sep 13, 2024 - Shares of Arcus Biosciences (RCUS) rise as Merck's data on Welireg disappoints in type of kidney cancer. Read more here.
0
Is Kohl's Setting Up For A Monster Short Squeeze?
https://seekingalpha.com/article/4720848-is-kohls-kss-stock-setting-up-for-a-monster-short-squeeze?source=feed_all_articles
Sep 12, 2024 - Short sellers have heavily targeted Kohl's in 2024, with short interest ballooning to 36% of diluted shares. Read here to know why we rate KSS stock a buy.
0
Markets Up for the Week (So Far) on Inflation and Jobs
https://www.zacks.com/stock/news/2335569/markets-up-for-the-week-so-far-on-inflation-and-jobs?cid=CS-ZC-FT-ahead_of_wall_street-2335569
Sep 12, 2024 - On the path to a lower Fed funds rate next week for the first time in years, CPI, PPI and Jobless Claims numbers performed decently.
0